<DOC>
	<DOCNO>NCT01681134</DOCNO>
	<brief_summary>The purpose study evaluate drug profile ( pharmacokinetics ) effect ( pharmacodynamics ) Advagraf® Prograf® kidney .</brief_summary>
	<brief_title>A Comparison Effects Extended Release Tacrolimus ( Advagraf® ) v . Immediate Release Tacrolimus ( Prograf® ) Kidney Function Healthy Male Volunteers</brief_title>
	<detailed_description>This 2 Period study . In Period 1 , subject assign randomly receive Advagraf® Prograf® administer twice daily , respectively , period 10 day . In Period 2 , subject convert Advagraf® Prograf® Prograf® Advagraf® 10 additional day dose . Dose adjustment make base monitoring drug level blood .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Caucasian No previous/current history infection , cerebrovascular , neurological , cardiovascular , endocrine , pulmonary , immunologic metabolic disease significant systemic disease , glucose intolerance , gout hematological disorder Normal 12lead Electrocardiogram ( ECG ) Systolic blood pressure &lt; 140 mm Hg diastolic blood pressure &lt; 90 mm Hg Nonsmoker within 3 month prior screen Willing abstain alcohol study Positive screen illicit drug alcohol consumption Subject hepatitis B , hepatitis C , human immunodeficiency virus ( HIV ) history cancer ( exclude completely excise squamous basal cell carcinoma ) Positive tuberculin skin test know history tuberculosis infection Known history serious head injury , seizure eat disorder Body Mass Index &lt; 18.0 &gt; 30.0 History renal dysfunction , clinically significant creatinine clinically significant abnormal liver function test , hemoglobin &lt; 130 g/L Plasma donation ≥ 500 mL within 7 day prior first dose study drug , donation whole blood loss 50499 mL within 30 day ≥ 499 mL within 56 day prior first dose study drug . Drug alcohol abuse within 1 year prior study entry Steroid injection within 12 week prior first dose study drug Live vaccine within 7 day prior first dose study drug</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>tacrolimus</keyword>
	<keyword>Advagraf®</keyword>
	<keyword>Prograf®</keyword>
	<keyword>Glomerular Filtration Rate</keyword>
	<keyword>Effective Renal Plasma Flow</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>